Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Reports that Bassam Kanaan, executive vice president of corporate development and M&A, sold 35,000 shares at 1,960 pence each for £686,000 on Thursday. He subsequently sold 10,000 shares at 2,025p each for £202,500. Proceeds for the disposals total £888,500. Both transactions took place on the London Stock Exchange.

Current stock price: 1,998.55p, down 0.2% in London on Tuesday morning

12-month change: down 6.9%

Copyright 2024 Alliance News Ltd. All Rights Reserved.